Evaluation of Multimodality Breast Imaging: Lesion Staging

University of Pennsylvania1 个研究点分布在 1 个国家目标入组 400 人2002年3月1日

适应症Breast Cancer

干预措施MRI, Digital Mammography, Ultrasound and Positron Emission Tomography (PET)

概览

阶段: 不适用
干预措施: MRI, Digital Mammography, Ultrasound and Positron Emission Tomography (PET)
疾病 / 适应症: Breast Cancer
发起方: University of Pennsylvania
入组人数: 400
试验地点: 1
状态: 进行中（未招募）
最后更新: 上个月

概览研究者入排标准研究组 & 干预措施结局指标研究点相似试验

概览

简要总结

This project is aimed at investigating the relative diagnostic and synergy of four state of the art breast imaging techniques (magnetic resonance imaging (MRI), full-field digital mammography (DMAM), ultrasound, and positron emission tomography (PET)) with respect to determining the extent of breast cancer.

注册库

clinicaltrials.gov

开始日期

2002年3月1日

结束日期

2027年3月12日

最后更新

上个月

研究类型

Interventional

研究设计

Single Group

性别

Female

研究者

发起方

University of Pennsylvania

责任方

Sponsor

入排标准

入选标准

•Women recently diagnosed with Breast Cancer
•Will be undergoing surgery (after study) at the Hospital of the University of Pennsylvania

排除标准

•Contraindications to MRI
•previously diagnosed with breast cancer (in the smae breast) within the past 5 years
•Patients with known locally advanced cancer (prior to study entry) being treated with preoperative adjuvant therapy.
•Pregnant women